Francesca Maria Q.
- Country
- Italy
- Department
- Ematologia
Research Overview
Data & Insights
Has run more than one trial at 0 of 14 partner sites.
Specializations
Hematologic Oncology
Investigator concentrates on malignant disorders of the blood and bone marrow.
- Acute Myeloid Leukemia
- Chronic Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Chronic Lymphocytic Leukemia
- Myelofibrosis
All studies are performed at Università degli Studi di Verona within the Department of Ematologia.
Solid Tumor Oncology
Research addresses a broad spectrum of epithelial cancers, emphasizing targeted and immunologic therapies.
- Non‑Small Cell Lung Cancer
- Breast Cancer
- Ovarian Cancer
- Pancreatic Adenocarcinoma
- Bladder Cancer
Clinical investigations integrate molecular profiling to refine therapeutic selection.
Cardiovascular and Metabolic Medicine
Investigator explores disease mechanisms and prevention strategies for vascular and metabolic disorders.
- Atherosclerotic Cardiovascular Disease
- Heart Failure
- Type 2 Diabetes Mellitus
- Obesity
- Chronic Kidney Disease
Efforts include evaluation of inflammatory pathways and renal‑cardiac interactions.
Autoimmune and Inflammatory Disorders
Focus is placed on immune‑mediated diseases affecting joints, nerves, and connective tissue.
- Psoriatic Arthritis
- Multiple Sclerosis
- Systemic Lupus Erythematosus
- Inflammatory Myopathies
- Eosinophilic Granulomatosis with Polyangiitis
Studies aim to modulate pathogenic immune pathways and improve functional outcomes.
Rare Genetic and Metabolic Disorders
Investigator contributes to therapeutic advances for inherited and uncommon metabolic conditions.
- Cystic Fibrosis
- Hypophosphatasia
- Osteogenesis Imperfecta
- Hemophilia A
- Hemophilia B
Research integrates genetic diagnostics with novel biologic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
